Ultrasound guided percutaneous tracheostomy
DeviceUltrasound guided percutaneous tracheostomy
NCT Number: NCT02656719
Trial is a randomized study to compare between ultrasound guided percutaneous tracheostomy and bronchoscopy guided percutaneous tracheostomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Trial is a randomized study to compare between ultrasound guided percutaneous tracheostomy and bronchoscopy guided percutaneous tracheostomy.
Patients will be randomly assigned to be submitted to evaluate safety, complication rates, easy to perform , clinical outcomes and effectivity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ultrasound guided percutaneous tracheostomy
Bronchoscopy guided percutaneous tracheostomy
Time frame: During percutaneous tracheostomy an expected average time 20 minutes
occurence of a major complications: bleeding, subcutaneous emphysema, oesophageal perforation, number of applied needle interventions, procedure duration, cardiorespiratory arrest
Time frame: during percutaneous tracheostomy ( average expected time 20 minutes)
the procedure duration was taken as the time that elapsed from the placement of the needle to the placement of the tracheostomy cannula.
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Pneumothorax due to the percutaneous tracheostomy detected by clinical examination during the procedure or chest x-ray after the procedure.
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Tracheal posterior wall injury as detected by bronchoscopy after the procedure
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Accidental decannulation after the procedure during Hospital stay
Time frame: during percutaneous tracheostomy an expected average of 20 minutes
Cardiorespiratory arrest due to percutaneous tracheostomy
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 4 weeks
Haemorrhage that could not be stopped by sponge wrapping the stoma after the procedure and/or blood coming with aspiration inside the tracheostomy tube was defined as minor bleeding
Time frame: During the procedure an expected average of 20 minutes
Continuous haemorrhage from the stoma and/or from the trachea with aspiration despite compresses was defined as a major haemorrhage.
Time frame: During percutaneous tracheostomy an expected average of 20 minutes
Drop in peripheral oxygen saturation < 90% for more than 2 minutes as measured by pulse oximeter during the procedure
Aykut Saritas
Other
Comparison Between Bronchoscopy and Real- Time Ultrasound Guided Percutaneous Dilatational Tracheostomy for Safety, Complications and Efficiency in Critically Ill Patient
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07701226
Head and Neck Neoplasms, Mouth Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01502657
Other Tracheostomy Complications, Tracheostomy Complications
Amiens, Somme, France
View Trial DetailsNCT07149116
Tracheostomy Complications
Aarhus, Denmark
View Trial DetailsNCT02084862
Tracheostomy Complications
São Paulo, Brazil
View Trial Details